INOD Innodata Inc

Previous close
$38.47
Est. 12 months change
+154.94%
Projected Price
$98.68

Profitability Metrics

Return on Equity (ROE)
37.59%
Return on Assets (ROA)
20.45%
Return on Invested Capital (ROIC)
88.77%
Weighted Average Cost of Capital (WACC)
18.94%
ROIC - WACC
69.83%
Updated : 2026-04-03 20:53 ET

Valuation Metrics

P/E Ratio
42.04
Forward P/E
51.94
PEG Ratio
-
Debt Current Ratio
2.68

Growth & Cash Flow

Gross Margin
39.84%
Operating Margin
15.84%
FCF Margin
14.16%
TTM Revenue Growth
22.30%
Projected 12M EPS Growth
-19.05%

Price Change

Price % from 50 SMA
-14.61%
Price % from 200 SMA
-27.65%
6 Months
-55.99%
1 Year
1.64%
2 Years
469.08%
Click here to see the list of ETFs containing INOD as a top holding :Innodata Inc ETFs

Analysis

Company Overview

Innodata is a digital services and technology company providing AI-enabled data annotation, content engineering, and digital transformation services to enterprise and publishing clients. Sector: Technology.

Overview

Innodata Inc (INOD) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

Profitability & Capital Efficiency

On the question of capital productivity, ROIC is 88.77%, WACC is 18.94%, and the economic spread is 69.83%. On balance, the spread between returns and capital costs is exceptional, meaning reinvested capital is creating significant incremental value at the company level. Supporting metrics show ROE at 37.59% and ROA at 20.45%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company with credible compounding capacity if current operating execution persists.

Valuation

From a market pricing perspective, trailing P/E of 42.04, forward P/E of 51.94. With trailing and forward P/E closely aligned, the market appears to be pricing the company on the assumption that earnings remain broadly stable near term. The company carries a current ratio of 2.68, pointing to strong short-term financial health. The overall valuation picture is one where the market is paying for a specific earnings and growth outcome — and where any deviation from that path would likely pressure multiples.

Margins & Cash Generation

The margin stack reads as follows: gross margin sits at 39.84%, operating margin at 15.84%, and free cash flow margin at 14.16%. Gross margins are in the moderate range, typical of sectors where direct costs consume a larger share of revenue. The company's operating margins are solid, pointing to overhead management that appears to be a relative strength. FCF margins are in a reasonable range, though there is room for improvement in how efficiently revenues convert to free cash. The profile is not weak, but it is uneven enough that execution and cost control remain central to the forward case.

Growth & Forward Outlook

Where growth and expectations intersect, the estimated 12-month price change of 156.50%, where the forward target set implies considerable headroom versus current levels, while TTM revenue growth of 22.30% suggesting the company is collectively capturing meaningful market share or pricing power. The forward EPS growth estimate of -19.1% is negative, which complicates the valuation case and suggests current multiples may not be as defensible on a forward basis. Both signals are useful lenses, but they tend to diverge most sharply near inflection points in both business fundamentals and market sentiment. The durability of both the operating trend and analyst optimism will determine whether the current setup translates into measurable near-term returns. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

Putting all the pieces together, the fundamental picture is one of the more convincing setups in these metrics — strong capital returns, reasonable pricing, and a healthy forward outlook.

This assessment is based solely on the quantitative metrics presented above and does not constitute financial advice. Investors should consider their own risk tolerance and conduct independent research before making investment decisions.